TCR2 Therapeutics Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c5487d38-8ea7-44bd-838d-8a8902dd2b7d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-153.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009312 |
| FY 2021 | $-99.7M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004299 |
| FY 2020 | $-68.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013563 |
| FY 2019 | $-51.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013856 |
| FY 2018 | $-26.5M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-013856 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).